How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen

Paul L. Reiter; Noel T. Brewer; Sami L. Gottlieb; Annie Laurie McRee; Jennifer S. Smith

doi:10.1016/j.vaccine.2009.09.016

How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen

Paul L. Reiter
, Noel T. Brewer
, Sami L. Gottlieb
, Annie Laurie McRee
, Jennifer S. Smith

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

We examined the prevalence of reported pain following human papillomavirus (HPV) vaccination and whether it differed from that for other adolescent vaccines or affected completion of the HPV vaccine regimen. In 2008, we conducted cross-sectional surveys with parents of adolescent girls aged 11-20 living in areas of North Carolina with elevated cervical cancer rates who had received at least one dose of HPV vaccine. Pain from HPV vaccination, while commonly reported by parents, was less frequent compared to other adolescent vaccines and did not appear to affect vaccine regimen completion. These findings may be important to increase HPV vaccination coverage.

Original language	English (US)
Pages (from-to)	6840-6844
Number of pages	5
Journal	Vaccine
Volume	27
Issue number	49
DOIs	https://doi.org/10.1016/j.vaccine.2009.09.016
State	Published - Nov 16 2009

Bibliographical note

Funding Information:
Although we do not believe we have any conflicts of interest, we wish to share the following information in the interest of full disclosure. NTB, the study PI, received a research grant from Merck for a study in 2008–2009 of men's attitudes toward HPV vaccination. NTB has received no honoraria or consulting fees from Merck or GlaxoSmithKline. JSS has received research grants or contracts, honoraria, or consulting fees during the last 4 years from GlaxoSmithKline and Merck. No funds from GlaxoSmithKline or Merck funded these research activities. One co-author from the funding source, the CDC, (SLG) participated in conducting the study and in preparing and submitting this article, though she did not participate in the decision to fund the study.

Funding Information:
This study was funded by grants from the Centers for Disease Control and Prevention ( S3715-25/25 ), the American Cancer Society ( MSRG-06-259-01-CPPB ), and the National Cancer Institute ( R25 CA57726 ).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HPV
Side effects
Vaccine

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Publisher link

10.1016/j.vaccine.2009.09.016

Find It

Find It at U of M Libraries

Cite this

@article{bec407a8478d40ae8605e01d39bb987f,

title = "How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen",

abstract = "We examined the prevalence of reported pain following human papillomavirus (HPV) vaccination and whether it differed from that for other adolescent vaccines or affected completion of the HPV vaccine regimen. In 2008, we conducted cross-sectional surveys with parents of adolescent girls aged 11-20 living in areas of North Carolina with elevated cervical cancer rates who had received at least one dose of HPV vaccine. Pain from HPV vaccination, while commonly reported by parents, was less frequent compared to other adolescent vaccines and did not appear to affect vaccine regimen completion. These findings may be important to increase HPV vaccination coverage.",

keywords = "HPV, Side effects, Vaccine",

author = "Reiter, \{Paul L.\} and Brewer, \{Noel T.\} and Gottlieb, \{Sami L.\} and McRee, \{Annie Laurie\} and Smith, \{Jennifer S.\}",

note = "Funding Information: Although we do not believe we have any conflicts of interest, we wish to share the following information in the interest of full disclosure. NTB, the study PI, received a research grant from Merck for a study in 2008{\textendash}2009 of men's attitudes toward HPV vaccination. NTB has received no honoraria or consulting fees from Merck or GlaxoSmithKline. JSS has received research grants or contracts, honoraria, or consulting fees during the last 4 years from GlaxoSmithKline and Merck. No funds from GlaxoSmithKline or Merck funded these research activities. One co-author from the funding source, the CDC, (SLG) participated in conducting the study and in preparing and submitting this article, though she did not participate in the decision to fund the study. Funding Information: This study was funded by grants from the Centers for Disease Control and Prevention ( S3715-25/25 ), the American Cancer Society ( MSRG-06-259-01-CPPB ), and the National Cancer Institute ( R25 CA57726 ).",

year = "2009",

month = nov,

day = "16",

doi = "10.1016/j.vaccine.2009.09.016",

language = "English (US)",

volume = "27",

pages = "6840--6844",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "49",

}

TY - JOUR

T1 - How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen

AU - Reiter, Paul L.

AU - Brewer, Noel T.

AU - Gottlieb, Sami L.

AU - McRee, Annie Laurie

AU - Smith, Jennifer S.

N1 - Funding Information: Although we do not believe we have any conflicts of interest, we wish to share the following information in the interest of full disclosure. NTB, the study PI, received a research grant from Merck for a study in 2008–2009 of men's attitudes toward HPV vaccination. NTB has received no honoraria or consulting fees from Merck or GlaxoSmithKline. JSS has received research grants or contracts, honoraria, or consulting fees during the last 4 years from GlaxoSmithKline and Merck. No funds from GlaxoSmithKline or Merck funded these research activities. One co-author from the funding source, the CDC, (SLG) participated in conducting the study and in preparing and submitting this article, though she did not participate in the decision to fund the study. Funding Information: This study was funded by grants from the Centers for Disease Control and Prevention ( S3715-25/25 ), the American Cancer Society ( MSRG-06-259-01-CPPB ), and the National Cancer Institute ( R25 CA57726 ).

PY - 2009/11/16

Y1 - 2009/11/16

N2 - We examined the prevalence of reported pain following human papillomavirus (HPV) vaccination and whether it differed from that for other adolescent vaccines or affected completion of the HPV vaccine regimen. In 2008, we conducted cross-sectional surveys with parents of adolescent girls aged 11-20 living in areas of North Carolina with elevated cervical cancer rates who had received at least one dose of HPV vaccine. Pain from HPV vaccination, while commonly reported by parents, was less frequent compared to other adolescent vaccines and did not appear to affect vaccine regimen completion. These findings may be important to increase HPV vaccination coverage.

AB - We examined the prevalence of reported pain following human papillomavirus (HPV) vaccination and whether it differed from that for other adolescent vaccines or affected completion of the HPV vaccine regimen. In 2008, we conducted cross-sectional surveys with parents of adolescent girls aged 11-20 living in areas of North Carolina with elevated cervical cancer rates who had received at least one dose of HPV vaccine. Pain from HPV vaccination, while commonly reported by parents, was less frequent compared to other adolescent vaccines and did not appear to affect vaccine regimen completion. These findings may be important to increase HPV vaccination coverage.

KW - HPV

KW - Side effects

KW - Vaccine

UR - https://www.scopus.com/pages/publications/70350571161

UR - https://www.scopus.com/pages/publications/70350571161#tab=citedBy

U2 - 10.1016/j.vaccine.2009.09.016

DO - 10.1016/j.vaccine.2009.09.016

M3 - Article

C2 - 19765398

AN - SCOPUS:70350571161

SN - 0264-410X

VL - 27

SP - 6840

EP - 6844

JO - Vaccine

JF - Vaccine

IS - 49

ER -

How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen

Abstract

Bibliographical note

UN SDGs

Keywords

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this